Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-10-01 Sale | 2024-10-03 5:53 pm | SOLENO THERAPEUTICS INC | SLNO | Anish Bhatnagar CHIEF EXECUTIVE OFFICER | 21,633 | $49.43 | $1,069,306 | 719,553 (Direct) | View |
| 2024-08-28 Sale | 2024-08-30 6:33 pm | SOLENO THERAPEUTICS INC | SLNO | Anish Bhatnagar CHIEF EXECUTIVE OFFICER | 115,004 | $47.43 | $5,454,707 | 741,186 (Direct) | View |
| 2024-08-05 Sale | 2024-08-07 6:55 pm | SOLENO THERAPEUTICS INC | SLNO | Anish Bhatnagar CHIEF EXECUTIVE OFFICER | 127,344 | $45.6 | $5,806,696 | 856,190 (Direct) | View |
| 2024-07-01 Sale | 2024-07-03 5:56 pm | SOLENO THERAPEUTICS INC | SLNO | Anish Bhatnagar CHIEF EXECUTIVE OFFICER | 19,256 | $41.54 | $799,844 | 133,534 (Direct) | View |
| 2024-04-01 Sale | 2024-04-03 9:36 pm | SOLENO THERAPEUTICS INC | SLNO | Anish Bhatnagar CHIEF EXECUTIVE OFFICER | 18,980 | $41.34 | $784,645 | 152,790 (Direct) | View |
| 2024-01-25 Sale | 2024-01-29 5:42 pm | SOLENO THERAPEUTICS INC | SLNO | Anish Bhatnagar CHIEF EXECUTIVE OFFICER | 2,527 | $48.3 | $122,054 | 171,770 (Direct) | View |
| 2023-12-11 Sale | 2023-12-13 9:34 pm | SOLENO THERAPEUTICS INC | SLNO | Anish Bhatnagar Chief Executive Officer | 93,408 | $35.67 | $3,331,701 | 24,297 (Direct) | View |
| 2023-11-30 Sale | 2023-12-04 8:02 pm | SOLENO THERAPEUTICS INC | SLNO | Anish Bhatnagar Chief Executive Officer | 27,716 | $28.65 | $794,116 | 108,062 (Direct) | View |
| 2023-11-28 Sale | 2023-11-30 9:50 pm | SOLENO THERAPEUTICS INC | SLNO | Anish Bhatnagar Chief Executive Officer | 53,505 | $27.49 | $1,471,049 | 135,778 (Direct) | View |
| 2022-03-31 Purchase | 2022-04-04 4:06 pm | SOLENO THERAPEUTICS INC | SLNO | Anish Bhatnagar Chief Executive Officer | 60,000 | $0 | $0 | 490,227 (Direct) | View |
| 2022-01-21 Sale | 2022-01-25 5:50 pm | SOLENO THERAPEUTICS INC | SLNO | Anish Bhatnagar Chief Executive Officer | 39,033 | $0.373 | $14,559 | 370,227 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-07-17 Option Award | 2024-07-19 09:00 am | N/A N/A | SOLENO THERAPEUTICS INC | SLNO | Anish Bhatnagar CHIEF EXECUTIVE OFFICER | 850,000 | $0 | 983,534 (Direct) | View |
| 2024-01-04 Option Award | 2024-01-08 5:34 pm | N/A 2034-01-04 | SOLENO THERAPEUTICS INC | SLNO | Anish Bhatnagar Chief Executive Officer | 250,000 | $0 | 274,297 (Direct) | View |
| 2023-10-20 Exercise | 2023-12-13 9:32 pm | 2022-03-31 2027-03-31 | SOLENO THERAPEUTICS INC | SLNO | Anish Bhatnagar Chief Executive Officer | 4,000 | $0 | 198,926 (Direct) | View |
| 2023-10-20 Exercise | 2023-12-13 9:32 pm | N/A N/A | SOLENO THERAPEUTICS INC | SLNO | Anish Bhatnagar Chief Executive Officer | 2,143 | $1.75 | 198,926 (Direct) | View |
| 2023-10-20 Exercise | 2023-12-13 9:32 pm | N/A N/A | SOLENO THERAPEUTICS INC | SLNO | Anish Bhatnagar Chief Executive Officer | 3,500 | $2.5 | 198,926 (Direct) | View |
| 2023-10-20 Exercise | 2023-12-13 9:32 pm | N/A N/A | SOLENO THERAPEUTICS INC | SLNO | Anish Bhatnagar Chief Executive Officer | 4,000 | $4.5 | 198,926 (Direct) | View |
| 2023-10-20 Exercise | 2023-12-13 9:32 pm | 2023-05-08 N/A | SOLENO THERAPEUTICS INC | SLNO | Anish Bhatnagar Chief Executive Officer | 5,643 | $0.4425 | 198,926 (Direct) | View |
| 2023-05-26 Option Award | 2023-05-26 6:26 pm | N/A 2033-05-26 | SOLENO THERAPEUTICS INC | SLNO | Anish Bhatnagar Chief Executive Officer | 642,408 | $0 | 671,089 (Direct) | View |
| 2023-05-08 Option Award | 2023-05-10 5:28 pm | 2023-05-08 N/A | SOLENO THERAPEUTICS INC | SLNO | Anish Bhatnagar Chief Executive Officer | 5,643 | $0.4425 | 5,643 (Direct) | View |
| 2023-01-25 Option Award | 2023-01-27 6:10 pm | N/A 2033-01-25 | SOLENO THERAPEUTICS INC | SLNO | Anish Bhatnagar Chief Executive Officer | 115,000 | $0 | 115,000 (Direct) | View |
| 2022-07-27 Option Award | 2022-07-29 09:14 am | N/A 2032-07-27 | SOLENO THERAPEUTICS INC | SLNO | Anish Bhatnagar Chief Executive Officer | 1,100,000 | $0 | 1,100,000 (Direct) | View |
| 2022-01-28 Option Award | 2022-02-01 4:08 pm | N/A 2032-01-28 | SOLENO THERAPEUTICS INC | SLNO | Anish Bhatnagar See Remarks | 610,000 | $0 | 610,000 (Direct) | View |
| 2021-01-23 Tax Withholding(A) | 2021-01-26 8:20 pm | N/A N/A | SOLENO THERAPEUTICS INC | SLNO | Anish Bhatnagar Chief Executive Officer | 36,318 | $2.11 | 409,260 (Direct) | View |
| 2021-01-23 Tax Withholding | 2021-01-26 7:02 pm | N/A N/A | SOLENO THERAPEUTICS INC | SLNO | Anish Bhatnagar Chief Executive Officer | 36,318 | $2.11 | 4,060,780 (Direct) | View |
| 2021-01-08 Option Award | 2021-01-12 9:21 pm | N/A 2031-01-08 | SOLENO THERAPEUTICS INC | SLNO | Anish Bhatnagar See Remarks | 2,100,000 | $0 | 4,097,098 (Direct) | View |
| 2020-05-18 Option Award | 2020-05-20 5:48 pm | N/A 2030-05-18 | SOLENO THERAPEUTICS INC | SLNO | Anish Bhatnagar See Remarks | 350,000 | $0 | 350,000 (Direct) | View |
| 2020-01-23 Option Award | 2020-01-24 4:13 pm | N/A N/A | SOLENO THERAPEUTICS INC | SLNO | Anish Bhatnagar Chief Executive Officer | 381,000 | $3.35 | 381,000 (Direct) | View |